Renalytix AI PLC ADR (RNLX): Price and Financial Metrics Recent IPO

Renalytix AI PLC ADR (RNLX) Recent IPO

Today's Latest Price: $13.20 USD

0.31 (-2.29%)

Updated Dec 1 4:00pm

Add RNLX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

RNLX Stock Price Chart Interactive Chart >

Price chart for RNLX

RNLX Price/Volume Stats

Current price $13.20 52-week high $18.00
Prev. close $13.51 52-week low $9.91
Day low $12.74 Volume 82,500
Day high $13.87 Avg. volume 61,444
50-day MA $11.94 Dividend yield N/A
200-day MA $0.00 Market Cap 475.40M

Renalytix AI PLC ADR (RNLX) Company Bio

Renalytix AI Plc manufactures medical devices and equipment. It offers artificial intelligence for kidney disease. The company was founded on March 15,2018 and is headquartered in Penarth, the United Kingdom.

RNLX Latest News Stream

Event/Time News Detail
Loading, please wait...

RNLX Latest Social Stream

Loading social stream, please wait...

View Full RNLX Social Stream

Latest RNLX News From Around the Web

Below are the latest news stories about Renalytix AI plc that investors may wish to consider to help them evaluate RNLX as an investment opportunity.

RenalytixAI prices global offering; ADS trading commences on July 17

Renalytix AI (RNLX) has priced its global offering of 11M new ordinary shares, inclusive of 5,485,000 American Depositary Shares (ADSs), each representing two ordinary shares, at a price of $13.50/ADS and 30,000 ordinary shares at a price of £5.37/share in Europe and other countries outside U.S., for gross proceeds of...

Seeking Alpha | July 17, 2020

Read More 'RNLX' Stories Here

RNLX Price Returns

1-mo 1.23%
3-mo -12.06%
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8624 seconds.